Strong Growth Forecast for the Global Inhaled Nitric Oxide Market
Inhaled nitric oxide market continues to demonstrate strong momentum, supported by rising demand for advanced respiratory therapies, neonatal care, and critical care management. According to the latest analysis, the market was valued at USD 1160 million in 2024 and is projected to rise to USD 1265 million in 2025, reaching USD 2089 million by 2031, reflecting a robust CAGR of 9.0% during the forecast period. This growth underscores the increasing importance of inhaled nitric oxide (iNO) as a life-saving therapeutic in pulmonary hypertension, ARDS, and respiratory support across diverse patient populations.
As healthcare providers adopt safer, more efficient nitric oxide delivery systems and clinical research expands therapeutic indications, the inhaled nitric oxide market is positioned for continuous expansion through 2032.
Uncover Complete Market Intelligence Here https://www.24lifesciences.com/inhaled-nitric-oxide-market-6937
Market Highlights: Inhaled Nitric Oxide Market Segmentation & Growth Drivers
The global market is segmented into type, application, end user, delivery system, and regulatory approval status, each contributing to the evolving competitive landscape.
By Type
- 800 ppm
- 100 ppm
- Others
The 800 ppm segment remains the dominant category due to widespread clinical utilization, especially in neonatal intensive care units (NICUs). However, lower-concentration systems are gaining preference in pediatric and adult therapy applications.
By Application
- Near-term and Pre-term Infants PPHN
- Children and Adult ARDS
- Other Diseases
Persistent Pulmonary Hypertension of the Newborn (PPHN) represents the largest application area, with significant clinical reliance on iNO therapy to stabilize oxygenation. Meanwhile, the rising incidence of Acute Respiratory Distress Syndrome (ARDS) intensified by post-pandemic complications has accelerated iNO’s adoption among adult populations.
By End User
- Hospitals
- Specialty Clinics
- Academic and Research Institutes
Hospitals account for the major revenue share due to their advanced infrastructure and higher uptake of ventilatory support systems. Specialty clinics and research organizations continue to expand utilization for off-label and investigational uses.
By Delivery System
- Cylinder-Based Systems
- Generator-Based Systems
- Integrated Ventilator Systems
Generator-based nitric oxide systems are emerging as a preferred alternative due to reduced operational cost and improved safety. Integrated ventilator systems are also seeing wider adoption for continuous respiratory support.
By Regulatory Approval Status
- FDA-Approved Indications
- Off-Label Use
- Investigational/Clinical Trials
While FDA-approved indications primarily neonatal therapy remain the primary revenue generators, the market is increasingly shaped by off-label applications and new clinical trial pipelines aimed at expanding therapeutic scope in adult respiratory care.
Discover Market Highlights – Request Free Sample Copy https://www.24lifesciences.com/download-sample/6937/inhaled-nitric-oxide-market
Key Market Growth Drivers
- Increasing prevalence of neonatal respiratory disorders
- Rising adoption of advanced critical care systems
- Demand for non-invasive and targeted pulmonary therapies
- Technological innovations in portable and digital delivery systems
- Expanding clinical trials for new respiratory indications
Emerging Trends Shaping the Healthcare & Life Sciences Market
The healthcare industry is undergoing rapid transformation, influenced by artificial intelligence, digital health platforms, precision medicine, and integrated monitoring systems. These advancements are reshaping respiratory diagnostics, ventilation management, and personalized care pathways.
In the inhaled nitric oxide market, digital integration such as AI-enabled dose regulation and real-time monitoring is enabling safer, more controlled therapy delivery. Moreover, the shift toward sustainability is pushing manufacturers to innovate eco-friendly alternatives to traditional nitric oxide cylinders.
These emerging healthcare trends are expected to accelerate market expansion and enhance global demand for advanced iNO delivery technologies through 2032.
Key Players & Competitive Landscape
The inhaled nitric oxide market is moderately consolidated, with global players focusing on product innovation, regulatory approvals, strategic collaborations, and R&D investments. Major companies profiled include:
- Mallinckrodt plc
- Linde plc (Praxair)
- Air Liquide
- BOC Healthcare (Linde Group)
- Nu-Med Plus
- Ikaria
- VERO Biotech
- Beyond Air, Inc.
- Circassia Pharmaceuticals
- Mylan N.V. (Viatris)
- GE HealthCare
- Getinge AB
- ALung Technologies, Inc.
- Messer Group
- Air Products and Chemicals, Inc.
These companies continue to drive market growth through innovations such as portable generators, integrated ventilation modules, and cost-efficient nitric oxide delivery platforms.
Discover Market Highlights – Request Free Sample Copy https://www.24lifesciences.com/download-sample/6937/inhaled-nitric-oxide-market
Forecast Overview
With a projected 9.0% CAGR, the inhaled nitric oxide market is expected to experience strong long-term expansion, supported by rising respiratory disease prevalence, neonatal healthcare advancements, and continuous innovation in gas delivery systems. As emerging markets invest in critical care infrastructure, global demand for inhaled nitric oxide will continue to increase, strengthening the competitive landscape through 2032.
About 24lifesciences
Founded in 2017, 24LifeScience has emerged as a trusted research and analytics partner for organizations operating within the global life sciences and chemical industries. Our core mission is to provide intelligent, future-ready insights that help clients stay ahead in an increasingly complex and innovation-driven market
International: +1(332) 2424 294 | Asia: +91 9425150513 (Asia)
Website: www.24lifesciences.com
Follow us on LinkedIn: www.linkedin.com/company/lifesciences24
